This announcement is a separate document:
北京市中伦律师事务所关于奥精医疗科技股份有限公司调整 2023 年限制性股票激励计划授予价格、首次授予部分第一个归属期符合归属条件及部分限制性股票作废事项的法律意见书
Legal opinion of Beijing Zhonglun Law Firm on Aojing Medical Technology Co., Ltd. adjusting the grant price of the 2023 restricted stock incentive plan, meeting the ownership conditions for the first time, and the cancellation of some restricted shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.